Why Cancer Researchers Are Tackling Twists In DNA

In the preface to The Double Helix, James Watson wrote of his intuition that DNA's structure would be "simple as well as pretty." While the double-helical molecule turned out to be elegant indeed, its structure poses complex problems. For example, how does DNA undergo replication - which involves unraveling and supercoiling - without tying itself into a mass of knots and tangles? The solution to DNA's topological problems comes in the form of enzymes called topoisomerases that serve as "swivel

Written byDavid Pendlebury
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The solution to DNA's topological problems comes in the form of enzymes called topoisomerases that serve as "swivels" and allow the molecule to perform its requisite acrobatics. Type I topoisomerase breaks one strand of the DNA, and Type II topoisomerase breaks both strands of the helix.

Since 1980 there has been a notable increase in research on topoisomerases. The number of 1988 papers indexed in the Institute for Scientific Information's on-line database SciSearch having the word topoisomerase and variants in their titles was 10 times the number indexed in 1980 (see accompanying graph). James C. Wang, Harvard University, a key player in this field who first identified the enzyme in 1971, confirmed that the 1980s has been a period of rapid growth in topoisomerase research. He noted, however, that The Scientist's graph might slightly underrepresent the amount of work produced in 1980-1982, since the term topoisomerase was not coined until ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies